Tag: MASLD

Medical illustration showing liver fat reduction with survodutide treatment in clinical trial
New StudiesResearch Digest

Weekly Dual-Hormone Injection Reduces Liver Fat by 67% in Obesity Trial

Phase 3 trial shows weekly survodutide injections reduced liver fat by 67% and achieved 18.5% weight loss in adults with…

By
GMJ Research Desk

Submit Your Paper to GMJ

No APC until January 2027.
Submit Manuscript →
Operated by the Public Health Institute of Georgia (PHIG) · non-profit, ID 404407815 · 3 Betlemi Rise, Tbilisi 0105, Georgia · info@accreditation.ge · Policy Framework · Legal notice · Privacy · Accessibility · Part of the PHIG network